Male Hormonal Contraceptive Development-ACY-5

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Contraception
Interventions
DRUG

Acyline

Acyline 300 mcg/kg SQ every 2 weeks for 12 weeks

DRUG

Testosterone Gel

Testosterone Gel (10 g daily

DRUG

Depo-Medroxyprogesterone

DMPA (injected into muscle) Day 0 \& month 3

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

CONRAD

OTHER

lead

University of Washington

OTHER

NCT00161447 - Male Hormonal Contraceptive Development-ACY-5 | Biotech Hunter | Biotech Hunter